Patent Grant
8980093
1. Field of the Invention
The present invention relates to a multicapillary sample preparation device especially useful for handling biological samples. In particular, the multicapillary device is suitable for use with a pipette, micropipette, syringe, or other similar analytical instrument.
2. Background Art
Many biological samples are commonly separated by gel electrophoresis and analyzed by matrix assisted laser desorption/ionization mass spectrometry (MALDI-MS). One disadvantage of these techniques, however, is that analysis is strongly affected by the presence of salts, buffers and low molecular weight organic compounds commonly used in the preparation of biological samples. In order to improve the sensitivity and selectivity of analyses, adsorptive and membranous devices are frequently used to purify and concentrate the sample prior to analysis. Such devices feature a bed of porous adsorbent or a semipermeable membrane fixed in a housing of a suitable dimension and shape that traps desired constituents, while allowing contaminants to pass.
To handle samples in the 0.01 to 100 microgram (μg) range, pipettes, micropipettes, syringes or similar analytical instruments (collectively referred to hereinafter as “pipettes”) are commonly employed. The tip of these pipettes is fitted with one or more adsorptive or membranous plugs capable of purifying, concentrating, or fractionating peptides and other biomolecules.
A principal shortcoming of adsorptive and membranous plugs, however, is that porous materials are generally not effective at separating smaller biomolecules such as proteins and polynucleotides. Porous plugs are also deficient with respect to isolating and purifying larger biological materials and nucleic acids such as DNA, RNA and cells. This shortcoming derives from the fact that during sample processing, molecules must wend through a labyrinth of sponge-like, expansive and porous adsorbent silica.
There is little uniformity, consistency, and reproducibility of porous materials used for sample preparation. Sample loss in existing pipette tips is typically about 40-60%. Poor sample recovery is largely due to the fact that a sample must travel through irregular voids in the porous material, whereby a portion of the sample lodges in small voids and is unrecoverable. Moreover, in order to achieve adequate results, samples must be passed through porous materials multiple times (e.g., ten). The sample preparation devices are usually not reusable and fit poorly with automatic instrumentation because poor sample recovery may give rise to contamination due to sample carry-over.
Spin columns and other apparatus operated by a centrifuge rotor are commonly used for the isolation and purification of biological and nucleic acid samples. However, it is desirable in certain applications to avoid the use of a centrifuge for rotating a specimen to be isolated and purified. This is due, in part, to the fact that horizontal separation may result in centrifugal forces of up to, for example, 4,000 RPM, being exerted on or transmitted along the vertical axis of the spin column and sample in order to achieve satisfactory separation. Air resistance negatively affects the spin column by generating drag and friction, which heat the spin column and its contents. Considerable breakage of sample fragments is unavoidable due to the heat transfer, acute centrifugal force and accompanying air resistance. The impaired quality of biological and nucleic acid samples extracted during spin column and centrifugal processing is highly undesirable to the user.
It can be seen, therefore, that the purification and concentration of biological and nucleic acid samples using porous materials prior to instrumental analysis is time consuming, is poorly reproducible, has low throughput, and requires repeated passing of a sample through the porous plug.
Accordingly, it is an object of the present invention to provide an efficient sample preparation device for use in isolating (immunoassay), purifying and concentrating samples of proteins, peptides, nucleic acids (e.g., DNA and RNA), and other biological materials (e.g., cells) prior to analysis.
It is also an object of the invention to provide a sample preparation device with high sample capacity that increases throughput and reduces sample loss.
It is a further object of the invention to provide a highly reproducible sample preparation device that achieves uniformity, consistency, and nearly identical pathways for sample passage.
It is a still further object of the invention to provide a sample preparation device that is simple, cost-effective, and does not require the use of a silica type porous substrate or special equipment such as a centrifuge.
The invention is a high surface area multicapillary sample preparation device especially useful for handling biological samples. The multicapillary device does not require use of a silica type porous substrate. Rather, the device incorporates a plurality of parallel capillary tubes, wherein the cavity of each tube remains open and unobstructed throughout sample processing. The capillary tubes of the device function independently of one another so that sample molecules are incapable of being physically exchanged or diffusing from one capillary to another. The multicapillary device is preferably disposed in a housing that is suitable for attachment to a “pipette” or other sample preparation or analytical instrument, enabling the isolation, purification, concentration and/or fractionation of nucleic acids or biological samples in the micro- and nanoliter range, as well as larger mass loads and volumes. In an embodiment of the invention, the multicapillary device features a monolithic element pierced with multiple uniform capillaries. The monolithic element is typically mounted in the lower end of a pipette tip, syringe needle or tubing, and is operated using a pipette.
For protein separation and purification applications, an insoluble stationary phase material is deposited onto the interior surfaces (walls) of each capillary tube, without employing a supporting or intermediary constituent.
The invention also includes a method of preparing a multicapillary device for protein sample preparation. In such method, inner walls of the capillary tubes are first coated with a stationary phase material, and then the monolithic element is mounted in an appropriate housing. Alternatively, the monolithic element can first be fixed in a housing, after which the capillary walls can be coated with the stationary phase. For operation, the multicapillary sample preparation device is attached to a pipette, micropipette, tube, syringe or similar analytical instrument.
In accordance with the present invention, a parallel capillary array or multicapillary sample preparation device 12 is provided for use with commercially available pipettes to permit the isolation, purification, concentration and/or fractionation of biological samples in the micro- and nanoliter range, as well as larger mass loads and volumes. The invention includes both detachable and integrally embedded multicapillary devices 12 adapted for use with manual and automatic pipettes, micropipettes 20, syringes 22 and other sample handling or analytical instruments. Notably, the multicapillary device 12 does not require use of a silica type porous substrate.
Referring now to
For protein or peptide separation and purification applications, it is preferable to deposit an insoluble stationary phase 18 on imperforate inner walls of the capillary tubes 16. For the separation and purification of polar compounds such as nucleic acids (e.g., DNA and RNA), it is preferable that the insoluble stationary phase 18 comprise a polar material. In a preferred embodiment of the invention, the thickness of the stationary phase 18 is correlated with the radius of individual capillary tubes 16 to optimize efficiency of the multicapillary device 12. As a result, during application of the stationary phase 18, a greater amount settles on the inner surface of wider capillaries; while a smaller amount settles on the inner surface of narrower capillaries. Through this process, the capillaries 16 achieve quasi-uniformity, which substantially increases the efficiency of the multicapillary device 12. The following relationship for high peak efficiency has been derived by the inventors:
df(r)=cf·rn (Equation 1)
The stationary phase film thickness df is proportional to capillary radius r in power n, where n>1; cf is a constant.
In a more preferred embodiment, the thickness of the stationary phase coating 18 is proportional to the radius of the capillary tubes 16 in power n, where n is greater than 1.
To achieve the highest peak efficiency, the stationary phase thickness df is proportional to capillary radius r in power 3.
Stationary phase media 18 is retained on the interior surfaces of the imperforate, hollow capillary tubes 16 via stable chemical bonding or cross-linking. There is, therefore, no discharge of stationary phase media 18 into the mobile phase during separation, reducing sample contamination. In the open tubular system of the multicapillary device 12, supporting intermediary constituents and adsorptive and membranous plugs (e.g., porous adsorbent silica particles or fibers) are unnecessary. The lumen or inner cavity of each capillary tube 16 remains unobstructed and impediment free throughout the protein, peptide, nucleic acid or biological sample separation process. In this stable, surface-mediated mechanism of separation, sample molecules are incapable of diffusing between and through the imperforate walls of the capillary tubes 16 or from one capillary to another. Individual capillary tubes 16 remain physically and functionally independent of one another.
The multicapillary device for sample preparation 12 may be detachably mounted (mechanically) or fixedly inserted (e.g., by melting or adhesion) about the end portion of a pipette tip, needle, tubing or other housing of suitable shape and dimension that is attachable to a pipette 20. The multicapillary device 12 receives a sample in a mobile (liquid) phase at its first end, and a concentrated and purified sample, devoid of contaminants such as salts and buffers, is discharged at a second end of the device 12.
As shown in
As shown in
Due to the significant reduction in sample loss enabled by the open and unobstructed channel structure of the multicapillary device 12, it is unnecessary for sample to be passed through the separation materials multiple times, as required in existing porous silica plugs, particles (for proteins and peptides), and fibers (for DNA and RNA). As a result, the multicapillary device 12 is generally reusable and fits conveniently with automatic instrumentation because there is no contamination due to sample carry-over. In short, the present multicapillary device 12 demonstrates superior characteristics over conventional adsorptive and membranous plugs with respect to binding capacity, recovery, increased throughput, uniformity and reproducibility.
In one embodiment of the invention, the imperforate inner walls of the capillary tubes 16 include particles of inert material or a nodular or uneven surface for increasing the surface area of the multicapillary device 12. In such case, the inner wall may be altered using an etching process in combination with a solvent such as, for example, a mineral acid or base, or an organic acid or base.
The present invention encompasses the use of any stationary phase 18 and surface chemistry adapted for liquid chromatography and sample preparation applications. In some embodiments, the stationary phase media 18 deposited on inner surfaces of the capillary wall comprises a monolayer of organic molecules, biopolymers or larger particles. Such molecules and particles include, but are not limited to, hydrocarbons and their C-, N-, S-, and P-derivatives; proteins, nucleic acids, and polysaccharides; linear and cross-linked polysiloxanes and other polymers; and viruses and cells. In other embodiments, a stationary phase coating 18 is formed by treating inner surfaces of the capillaries 16 with organosilicone compounds and further modifying these groups with appropriate reagents and particles.
An alternative technique for the deposition of a stationary phase 18 involves polymerization of unsaturated compounds, such as butadiene, styrene, divinylbenzene, and others, on inner walls of the capillary tubes 16.
The techniques used for deposition of a stationary phase material 18, described in the following Examples, render the stationary phase material insoluble in organic and water-organic solvents commonly used in sample preparation and liquid chromatography, such as acetonitrile, methanol, isopropanol, acetone, dimethylsulfoxide, dimethylformamide and urea; acetic, iodoacetic, trifluoroacetic and formic acids; and phosphate, acetic and carbonate buffers, etc.
The multicapillary sample preparation device 12 is advantageously suited for use with a wide range of sample preparation and analytical instruments. As shown in
In other embodiments, the multicapillary device 12 is integrally and permanently embedded (e.g., cast-in-place) about the terminal region of a pipette tip 20 or other housing by melting, heat shrinking or adhesion in order to fuse the monolithic element 14 to the surface of a pipette tip 20 or other housing commonly made from polypropylene or other thermoplastic material. As an alternative, plasma and/or chemical means may be used to accomplish adhesion of the monolithic element 14 to the surface of the pipette tip 20 or other housing.
In yet another embodiment, the multicapillary device 12 is adapted to be detachably or fixedly engaged or aligned with the hollow flow passage(s) of a substantially cylindrical, conical or other housing configuration. The multicapillary device 12 is suitably sized and shaped to be integrated in housings of varying sizes and configurations. However, it is preferable that the housing have a volume in the range of about 0.1 μL to about 100 mL, more preferably in the range of about 1 to about 1000 μL, and most preferably in the range of about 2 to about 200 μL.
It will be understood that any technique used to install the multicapillary device 12 into a pipette tip or other housing for operation with a pipette 20 should accurately direct sample in a liquid phase through the capillary tubes 16 of the monolithic element 14 without bypassing the element 14. In such adaptation, the multicapillary device 12 receives the sample at its first end, and a concentrated and/or purified sample, devoid of contaminants such as salts and buffers, is discharged at a second end. The multicapillary device 12 of the present invention is freely permeable not only to proteins, peptides, polynucleotides, and other molecules and biopolymers, but also to viruses, spores, cells (e.g., cancer and stem), and microorganisms. It will be understood, however, that sample molecules are prevented from diffusing from one capillary tube 16 to another
Preferred materials for fabricating the monolithic element 14, capillary tubes 16, tips, pipettes 20, syringes 22 and other housings of the present invention include, but are not limited to, glass, fused silica, ceramic, metal (e.g., stainless steel), and plastic (e.g., polypropylene, polyethylene, polyolefin, or polyetheretherketone). In sample preparation and chromatographic applications, it is desirable to employ a large number (e.g. hundreds or thousands) of capillary tubes to provide an abundant surface area for higher sample loading capacity. It will be understood, however, that the number and dimensions of the multicapillary device 12, stationary phase media 18, solvent, tips and other housings employed in the invention will vary according to application.
As an example, the number of capillary tubes 16 provided in a multicapillary device 12 may range from about 100 to about 1,000,000. The inner diameter of each capillary tube 16 may range from about 0.1 μm to about 200 μm. The outer diameter of the monolithic element 14 may range from about 0.1 mm to about 1 m, and the length may range from about 0.1 mm to about 2 m. In a preferred embodiment, the number of capillary tubes 16 ranges from about 1000 to about 10,000, the inner diameter of each capillary ranges from about 5 μm to about 100 μm, the outer diameter of the monolithic element 14 ranges from about 1 mm to about 20 mm, and the length ranges from about 1 mm to about 250 mm.
A 5% solution of trimethylchlorosilane in toluene is pumped at 10 μL/min for six hours through a 1 mm outer diameter×250 mm long multicapillary glass rod pierced with approximately 4400 capillaries of 10 μm diameter at 105° C. The multicapillary rod is rinsed with toluene, acetone and methanol, and dried with a nitrogen stream.
A 10% solution of butyldimethylchlorosilane in toluene is pumped at 40 μL/min for six hours through a 2 mm outer diameter×300 mm long multicapillary glass rod pierced with approximately 4600 capillaries of 25 μm diameter at 105° C. The multicapillary rod is rinsed with toluene, acetone and methanol, and dried with a nitrogen stream.
A 10% solution of octyltrichlorosilane in toluene is pumped at 50 μL/min for six hours through a 2.3 mm outer diameter×250 mm long multicapillary glass rod pierced with approximately 1400 capillaries of 40 μm diameter at 105° C. The multicapillary rod is rinsed with toluene, acetone and methanol, and dried with a nitrogen stream.
A 5% solution of dodecyltrichlorosilane in toluene is pumped at 75 μL/min for six hours through a 6 mm outer diameter×300 mm long multicapillary glass rod pierced with approximately 3300 capillaries of 65 μm diameter at 105° C. The multicapillary rod is rinsed with toluene, acetone and methanol, and dried with a nitrogen stream.
A 10% solution of octadecyltriethoxysilane in toluene is pumped at 10 μL/min for six hours through a clean and dry 2.3 mm outer diameter×300 mm multicapillary glass rod pierced with approximately 4,000 capillaries of 20 μm diameter at 105° C. While pumping the solution, an opposite end of the multicapillary device is moved at a linear speed of 0.5 mm/min inside an oven heated to 150° C. The device is rinsed with toluene, acetone and methanol, and dried with a nitrogen stream.
Twenty 1 mm outer diameter×2.5 mm long multicapillary glass rods pierced with approximately 4400 capillaries of 10 μm diameter are placed in a flask containing 50 mL of a 5% solution of octadecyldimethylchlorosilane in toluene and equipped with a reflux condenser and a calcium chloride tube. The mixture is slowly refluxed for six hours. The liquid phase is separated and the multicapillary rods are repeatedly washed with toluene, tetrahydrofuran and methanol, and dried at room temperature.
In accordance with the conditions described in Example 6, the stationary phases with C-16, C-30, phenyl, naphthyl and cyano groups are prepared, correspondingly, from hexadecyltrichlorosilane, triacontyltrichlorosilane, phenethyltrichlorosilane, (1-naphthylmethyl)trichlorosilane and 3-cyanopropyltrichlorosilane.
Twenty 2.3 mm outer diameter×5 mm long multicapillary glass rods pierced with approximately 1400 capillaries of 40 μm diameter are placed in a flask containing 50 mL of a 5% solution of (3-glycidoxypropyl)trimethoxysilane in toluene and equipped with a reflux condenser. The mixture is slowly refluxed for five hours while the condenser is maintained at a temperature of 70° C. to remove the methanol formed from the reaction. The liquid phase is separated and the multicapillary rods are repeatedly washed with toluene, tetrahydrofuran and methanol, and dried at room temperature.
Twenty 2.3 mm outer diameter×3 mm long multicapillary glass rods pierced with approximately 1400 capillaries of 40 μm diameter are placed in a flask containing 50 mL of a 5% solution of (3-glycidoxypropyl)trimethoxysilane in toluene and equipped with a reflux condenser. The mixture is slowly refluxed for three hours while the condenser is maintained at a temperature of 70° C. The liquid phase is separated and the multicapillary rods are repeatedly washed with toluene, tetrahydrofuran, methanol and water. 50 mL of water is added and the pH is adjusted to 2.0 with nitric acid. The mixture is slowly agitated for two hours at room temperature. The liquid phase is separated and the multicapillary rods are washed with water until the wash is neutral, then washed three times with methanol, and dried at room temperature.
2.5 g of (3-glycidoxypropyl)trimethoxysilane is dropped into a flask containing 50 mL of water, while maintaining the pH between 5 and 6 with 0.01 M potassium hydroxide. Twenty 2.3 mm outer diameter×5 mm long multicapillary glass rods pierced with approximately 1400 capillaries of 40 μm diameter are placed in a flask. The mixture is slowly refluxed for three hours with a reflux condenser. The liquid phase is separated and the multicapillary rods are repeatedly washed with water, methanol and tetrahydrofuran. 50 mL of water is added and the pH is adjusted to 2.0 with nitric acid. The mixture is slowly agitated for two hours at room temperature. The liquid phase is separated and the multicapillary rods are washed with water until the wash is neutral, then washed three times with methanol, and dried at room temperature.
Twenty-five 1 mm outer diameter×2.5 mm long multicapillary glass rods pierced with approximately 4400 capillaries of 10 μm diameter are placed in a flask containing 50 mL of a 5% solution of 3-aminopropyltrimethoxysilane in toluene and equipped with a reflux condenser. The mixture is slowly refluxed for five hours while the condenser is maintained at a temperature of 70° C. The liquid phase is separated and the multicapillary rods are repeatedly washed with toluene, tetrahydrofuran and methanol, and dried at room temperature.
Thirty 2.3 mm outer diameter×5 mm long multicapillary glass rods pierced with approximately 1400 capillaries of 40 μm diameter are placed in a flask containing 50 mL of a 5% solution of 3-aminopropyltrimethoxysilane in toluene and equipped with a reflux condenser. The mixture is slowly refluxed for six hours while the condenser is maintained at a temperature of 70° C. The liquid phase is separated and the multicapillary rods are repeatedly washed with toluene, tetrahydrofuran and methanol. 30 mL of a 5% solution of trimethylamine in methanol is added to the flask. The flask is equipped with a calcium chloride tube, and the mixture is slowly agitated at 0-5° C. for 48 hours. The liquid phase is separated and the multicapillary rods are repeatedly washed with methanol, water, 0.01 M HCl, water and tetrahydrofuran, and dried at room temperature.
Twenty 2.3 mm outer diameter×5 mm long multicapillary glass rods pierced with approximately 1400 capillaries of 40 μm diameter are placed in a flask containing 50 mL of a 5% water solution of carboxyethylsilane triol (sodium salt). The pH is adjusted to 2.0 by adding hydrochloric acid. The mixture is slowly refluxed for three hours with a reflux condenser. The liquid phase is separated and the multicapillary rods are washed with water until the wash is neutral, then washed three times with methanol, and dried at room temperature.
Twenty-five 2.3 mm outer diameter×3 mm long multicapillary glass rods pierced with approximately 1400 capillaries of 40 μm diameter are placed in a flask containing 50 mL of a 5% water solution of 3-(trihydroxysilyl)-1-propanesulfonic acid. The mixture is slowly refluxed for three hours with a reflux condenser. The liquid phase is separated and the multicapillary rods are washed with water until the wash is neutral, then washed three times with methanol, and dried at room temperature.
Thirty 2.3 mm outer diameter×3 mm long multicapillary glass rods pierced with approximately 1400 capillaries of 40 μm diameter are placed in a flask containing 50 mL of a 5% water solution of (3-trihydroxysilylpropyl)methylphosphonate sodium salt. The mixture is acidified to pH 2.0 with HCL and slowly refluxed for three hours with a reflux condenser. The liquid phase is separated and the multicapillary rods are washed with water until the wash is neutral, then washed three times with methanol, and dried at room temperature.
Twenty 1 mm outer diameter×2.5 mm long multicapillary glass rods pierced with approximately 4400 capillaries of 10 μm diameter are placed in a flask containing 50 mL of a 5% solution of (3-glycidoxypropyl)trimethoxysilane in toluene and equipped with a reflux condenser. The mixture is slowly refluxed for five hours while the condenser is maintained at a temperature of 70° C. The liquid phase is separated and the multicapillary rods are repeatedly washed with toluene, tetrahydrofuran, methanol and water. 20 mL of a 2 M iminodiacetic acid solution in 0.1 M sodium borate buffer, pH 8.5, is added and the mixture is slowly agitated for 24 hours at room temperature. The liquid phase is separated and the multicapillary rods are washed with water until the wash is neutral, then washed three times with methanol, and dried at room temperature.
Twenty-five 1 mm outer diameter×2.5 mm long multicapillary glass rods pierced with approximately 4400 capillaries of 10 μm diameter are placed in a flask containing 50 mL of a 5% solution of 3-bromopropyltrimethoxysilane in toluene and equipped with a reflux condenser. The mixture is slowly refluxed for five hours while the condenser is maintained at a temperature of 70° C. The liquid phase is separated and the multicapillary rods are repeatedly washed with toluene, tetrahydrofuran and methanol. 50 mL of a 1% solution of cystein in methanol and 1 mL of triethylamine are added, and the mixture is slowly refluxed with a reflux condenser for five hours. The liquid phase is separated and the multicapillary rods are repeatedly washed with methanol, water, methanol and methylene chloride, and dried at room temperature.
Twenty 1 mm outer diameter×2.5 mm long multicapillary glass rods pierced with approximately 4400 capillaries of 10 μm diameter are placed in a flask containing 50 mL of a 5% solution of 11-bromoundecyltrimethoxysilane in toluene and equipped with a reflux condenser. The mixture is slowly refluxed for five hours while the condenser is maintained at a temperature of 70° C. The liquid phase is separated and the multicapillary rods are repeatedly washed with toluene, tetrahydrofuran and methanol. 50 mL of a 0.5% solution of glutathione in methanol and 1 mL of triethylamine are added, and the mixture is slowly refluxed with a reflux condenser for five hours. The liquid phase is separated and the multicapillary rods are repeatedly washed with methanol, water, methanol and methylene chloride, and dried at room temperature.
A 5% solution of (R)-N-1-phenylethyl-N′-triethoxysilylpropylurea in toluene is pumped at 10 μL/min for six hours through a 1 mm outer diameter×300 mm long multicapillary glass rod pierced with approximately 4000 capillaries of 10 μm diameter at 105° C. The multicapillary rod is rinsed with toluene, tetrahydrofuran and methanol, and dried with a nitrogen stream.
The 10% solution of vinyltrichlorosilane in isooctane is pumped at 20 μL/min for six hours through a 1 mm outer diameter×250 mm long multicapillary glass rod pierced with approximately 4,400 capillaries of 10 μm diameter at 90° C. The multicapillary rod is rinsed with isooctane, tetrahydrofuran, methanol, toluene and isooctane. A solution of 100 mg polybutadiene (MW 3,400) and 0.5 mg dicumyl peroxide in 100 mL of isooctane is pumped at 10 μL/min for six hours through the multicapillary rod at 90° C. The multicapillary rod is rinsed with toluene, tetrahydrofuran and methanol, and dried with a nitrogen stream.
Twenty five 1 mm outer diameter×2.5 mm long multicapillary glass rods pierced with approximately 4400 capillaries of 10 μm diameter are placed in a flask containing 50 mL of a 5% solution of 3-aminopropyltrimethoxysilane in toluene and equipped with a reflux condenser. The mixture is slowly refluxed for five hours while the condenser is maintained at a temperature of 70° C. The liquid phase is separated and the multicapillary rods are repeatedly washed with toluene, methanol and dimethylformamide. 15 mL of a saturated dimethylformamide solution of biotin, a solution of 0.3 g of 1-hydroxybenzotriazole hydrate in 10 mL of dimethylformamide, and a solution of 0.25 g of N,N′-dicyclohehylcarbodiimide in 10 mL of dimethylformamide are added, and the mixture is slowly agitated for five hours at room temperature. The liquid phase is separated and the multicapillary rods are repeatedly washed with dimethylformamide, methanol, water, methanol and methylene chloride, and dried at room temperature.
Twenty 2.3 mm outer diameter×2.5 mm long multicapillary glass rods pierced with approximately 1400 capillaries of 40 μm diameter are placed in a flask containing 50 mL of a 5% solution of 3-aminopropyltrimethoxysilane in toluene and equipped with a reflux condenser. The mixture is slowly refluxed for five hours while the condenser is maintained at a temperature of 70° C. The liquid phase is separated and the multicapillary rods are repeatedly washed with toluene, methanol, water and 0.05 M 2-morpholinoethane sulfonic acid buffer, pH 5.6. The 10 mL solution of 0.2 g heparin (from bovine kidney), 1 g N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide, and 0.5 g N-hydroxysuccinimide in 0.05 M 2-morpholinoethane sulfonic acid buffer, pH 5.6, is added. The mixture is slowly agitated for three hours at room temperature. The liquid phase is separated, and the multicapillary rods are repeatedly washed with water, phosphate buffer, pH 8, and 20% sodium chloride, and then washed with water and stored at 4° C.
Twenty 2.3 mm outer diameter×3 mm long multicapillary glass rods pierced with approximately 1400 capillaries of 40 μm diameter are placed in a flask containing 20 mL of a 5% solution of (3-glycidoxypropyl)trimethoxysilane in toluene and equipped with a reflux condenser. The mixture is slowly refluxed for five hours while the condenser is maintained at a temperature of 70° C. The liquid phase is separated and the multicapillary rods are repeatedly washed with toluene, methanol and water. The 4 mL solution of 100 mg alpha1 acid (from bovine plasma) in a 1:1 mixture of 0.4 M sodium chloride and 0.2 M borate buffer, pH 8.5, is added. The mixture is slowly agitated at room temperature for 48 hours. The liquid phase is separated. The multicapillary rods are repeatedly washed with a 1:1 mixture of 0.4 M sodium chloride and 0.2 M borate buffer, pH 8.5, then washed with water and stored at 4° C.
Twenty 2 mm outer diameter×5 mm long multicapillary glass rods pierced with approximately 4600 capillaries of 25 μm diameter are placed in a flask containing 20 mL of a 5% solution of (3-glycidoxypropyl)trimethoxysilane in toluene and equipped with a reflux condenser. The mixture is slowly refluxed for five hours while the condenser is maintained at a temperature of 70° C. The liquid phase is separated and the multicapillary rods are repeatedly washed with toluene, methanol and water. A 7 mL solution of 100 mg trypsin (from bovine pancreas) in 0.2 M phosphate buffer, pH 7.0, is added to the flask. The mixture is slowly agitated at room temperature for 15 hours, and the liquid phase is separated. The multicapillary rods are repeatedly washed with 0.2 M phosphate buffer, pH 7.0, water, 0.2 M Tris buffer, pH 7.5, for two hours, and then washed with water and stored at 4° C.
In accordance with the conditions described in Example 24, avidin, lectin and protein A stationary phases are prepared using avidin (from egg white), lectin (from Agaricus bisporus), and protein A (from Staphylococcus aureus), correspondingly.
Twenty 2.3 mm outer diameter×3 mm long multicapillary glass rods pierced with approximately 1400 capillaries of 40 μm diameter are placed in a flask containing 50 mL of a 5% solution of 10-(carbomethoxy)decyldimethylmethoxysilane in toluene and equipped with a reflux condenser. The mixture is slowly refluxed for three hours while the condenser is maintained at a temperature of 70° C. The liquid phase is separated, and the multicapillary rods are repeatedly washed with toluene, methanol and methylene chloride. A 35 mL solution of 1 mL trimethyliodosilane in methylene chloride is added. The mixture is slowly agitated for 72 hours at room temperature.
The liquid phase is separated and the multicapillary rods are repeatedly washed with methylene chloride, methanol, 90% methanol and water. 20 mL of 0.02 M ethyl(dimethylaminopropyl)-carbodiimide in 0.1 M 2-morpholinoethanesulfonic acid buffer, pH 4.5, is added, and the mixture is slowly agitated for one hour at room temperature. The liquid phase is separated, and 5 mL of the 5 μg/mL solution of ricin antibody in 0.1 M phosphate buffered saline, pH 7.2, is added. The mixture is slowly agitated for two hours at room temperature. The liquid phase is separated. The multicapillary rods are repeatedly washed with phosphate buffered saline, pH 7.2, then washed with water and stored at 4° C.
A 1 mm to 5 mm outer diameter multicapillary element 10, prepared as described in Example 6, is tightly pushed to the lower end of a polypropylene 10 μL to 5,000 μL volume micropipette tip. The lower portion of the pipette tip is placed for ten minutes in an oven thermostated at a temperature at which polypropylene begins to soften. Polypropylene pipette tip format multicapillary devices for sample preparation 12, 20 are shown in
A 1 mm to 5 mm outer diameter multicapillary element 10, prepared as described in Example 6, is tightly placed in the lower end of a disposable polyethylene transfer pipette. The lower portion of the pipette is placed for ten minutes in an oven thermostated at a temperature at which polyethylene begins to soften. A polyethylene pipette format multicapillary device for sample preparation 12, 20 is shown in
A 2 mm outer diameter multicapillary element 10, prepared as described in Example 5, is attached to a heat shrinkable tubing. A removable syringe needle is attached to the second end of the heat shrinkable tubing. The heat shrinkable tubing zone is heated at a temperature recommended for the shrinkable tubing for ten minutes A representative syringe format multicapillary device for sample preparation 12, 22 is shown in
A 2.3 mm outer diameter multicapillary element 10, prepared as described in Example 5, is tightly placed in a removable thermoplastic syringe hub. The hub is heated for ten minutes in an oven thermostated at a temperature at which thermoplastic begins to soften. Syringe format multicapillary devices for sample preparation 12, 22 are shown in
A three component mixture (uracil, fluorene, and phenanthrene) is separated on the multicapillary device for sample preparation prepared as described in Example 5 and installed on a model LC-600 Shimadzu liquid chromatographic instrument using standard HPLC fittings. The chromatographic conditions and chromatogram are reproduced in
Referring to
A 10 μL volume of 0.25 mg/mL bovine serum albumin solution in a 40:60 mixture of acetonitrile and 0.2 mM ammonium bicarbonate, pH 7.5, is aspirated in the multicapillary sample preparation device, prepared as described in Example 24, and thermostated at 37° C. After five minutes, the digested sample is dispensed in a vial and stored at 4° C.
The bovine serum albumin digest, prepared as described in Example 34, is dried with a nitrogen stream and dissolved in 10 μL of 0.1% trifluoroacetic acid (TFA) in water. 1 μL of this sample is aspirated and dispensed from the multicapillary sample preparation device, as described in Examples 5 and 27. Three 10 μL portions of 0.1% trifluoroacetic acid (TFA) in 5% acetonitrile/water are pumped in and out of the multicapillary sample preparation device. The sample is eluted from the multicapillary sample preparation device with a 5 μL portion of 0.1% TFA in 70% acetonitrile/water and analyzed by MALDI-MS. The MALDI-MS spectra of the sample before and after desalting are shown in
A 3 μL volume of the 100 pmole/μL peptide mixture obtained by the enzymatic hydrolysis of bovine serum albumin, as described in Example 34, is introduced into a 10 cm long C-18 multicapillary sample preparation device. The sample is eluted at 100 μL/min with 100 μL of 0.1% TFA in water followed by 30 μL of 0.1% TFA in 40% acetonitrile/water. Ten 3 μL 40% acetonitrile/water fractions are collected and analyzed by MALDI-MS. The mass-spectra of fractions 3 and 6 are shown in
The test sample used for electrophoresis is a mixture of the following four representative proteins: Phosphorylase B (MW 97,400), Bovine Serum Albumin (MW 66,200), Carbonic Anhydrase (MW 31,000), and Lysozyme (MW 14,400). These proteins were selected due to their varying size and generally known properties. Moreover, these proteins are commonly used as standards. All results were reproduced and retested several times to ensure accuracy. Testing was conducted at ChromBA, Inc. (State College, Pa.), The Materials Research Institute (University Park, Pa.), The Milton Hershey Medical Center (Hershey, Pa.), Huck Institute (University Park, Pa.), APD LifeSciences Inc. (State College, Pa.), and MassTech Inc. (Columbia, Md.). In total, over 40 gels were used, including both C18 and C4, the two most popular phases on the market. In addition, more than 500 sample preparation devices were tested.
In both figures, the conventional silica-based devices (
In contrast, Lanes 5-10 show nearly identical spots for samples passed through the multicapillary device of the present invention only once. Notably, the bands are much darker and broader than those of the silica-based devices, denoting the presence of vastly greater amounts of protein.
In
The following experiments, featuring both syringe 22 and pipette tip 20 format multicapillary devices 12, demonstrate the advantage of using a multicapillary device for sample handling and extraction of DNA from various biological samples, such as tissue, blood, bacterial cells, urine, etc.
A multicapillary device for sample preparation 12 (1 to 2.5 mm outer diameter, 0.25 to 3 cm long, approximately 4000 capillaries of 10 to 40 μM diameter, inner volume 2 to 90 μL) is loaded twice with 10 to 1,000 μL lysed biological sample. After discarding the loading solution, the multicapillary device 12 is rinsed with a washing buffer to dispose of proteins and other non-DNA type materials. Adsorbed DNA is then eluted with 10 to 300 μL elution buffer. The eluted DNA is analyzed using a variety of methods including Yo-Pro fluorescence on a Packard FluoroCount instrument at 530 nm (for yield determination), Agarose gel electrophoresis (for quality determination), and pulsed field gel electrophoresis (for DNA size and quality determination).
Agarose gel electrophoresis and pulsed field gel electrophoresis analyses were performed to determine DNA quality and size.
As demonstrated in
Table 3 shows the absorbance reading of five multicapillary devices 12 prepared according to the method described above. The average DNA recovery yield is 50-60%, which demonstrates that the multicapillary device for sample preparation 12 is efficacious for sample handling, purification and isolation of nucleic acids.
To demonstrate the use of a multicapillary device 12 for sample handling of cells, the following cells are grown and evaluated: mouse myeloma Sp2/0-Ag14, approximately 25 μm size; mouse macrophage J774A1, approximately 15 μm size; and human prostrate tumor THP-1 approximately 20 μm size. A syringe format multicapillary device for sample preparation 12, 22 (2.3 mm outer diameter, 150 mm long, approximately 1400 capillaries of 40 μm diameter, inner volume 262 μL) is attached to a syringe and rinsed with 1 mL of balanced salt solution creating an environment conductive to cell viability. At room temperature, a 1.5-3.0 mL volume of cell suspension is passed through the multicapillary device at a flow rate of 1 mL/min, followed by a 0.5 mL volume of balanced salt solution. The eluted cell suspension is concentrated by centrifugation and cells are counted using a hemacytometer. The change in cell viability after passage through the multicapillary device is presented in Table 4.
The data reveal that the vast majority of each cell type passed through the device emerges unharmed. Therefore, the multicapillary device for sample preparation is highly efficacious for sample handling of cells.
Manufacturers of existing pipette tips state in their technical literature that 40-60% sample loss is average for a purified product. In comparison, the increased capacity and recovery afforded by the present invention substantially reduces and/or eliminates the critical problem of sample loss in the pipette tip. Moreover, equipment wear is reduced, since the present invention eschews repeat sample passage, as required by conventional silica-based devices.
As demonstrated by the foregoing Examples 1-38, the multicapillary device 12 of the present invention enables a user to achieve superior sample preparation results in significantly less time. Indeed, the device's 12 ability to return quality results quickly and reproducibly permits a user to increase the throughput of available sample preparation stations at least several times, depending upon the sample and system employed.
In short, the multicapillary sample preparation device 12 of the present invention advantageously increases sample throughput and decreases variance in a highly reproducible fashion. The multicapillary device 12 may be used in an array of applications without departing from the scope of the invention. These include, but are not limited to, sample handling of small molecules, polymers, viruses and cells; the isolation, purification, concentration, desalting and fractionation of biological samples and nucleic acids, including DNA and RNA; solid phase extraction; head space analysis; gas chromatography; liquid chromatography (e.g., HPLC); supercritical chromatography; electrochromatography; and capillary electrophoresis.
Representative examples of the above-mentioned applications include: sample preparation of biological samples such as proteins, peptides, and polynucleotides, fractionation of peptide mixtures prior to mass-spectrometric analysis, desalting of samples prior to instrumental analysis, desalting of peptide solutions, desalting of protein solutions, sample concentration prior to instrumental analysis, and peptide concentration prior to mass-spectrometric analysis.
While the invention has been particularly shown and described with reference to the examples and preferred embodiments thereof, it will be understood by those skilled in the art that various alterations in form and detail may be made therein without departing from the spirit and scope of the invention.
This application is a continuation of U.S. patent application Ser. No. 11/524,426, filed Sep. 20, 2006, which is a continuation-in-part of U.S. patent application Ser. No. 10/955,377 filed Sep. 30, 2004 (issued as U.S. Pat. No. 7,166,212), which claims the benefit of U.S. Provisional Patent Application No. 60/507,474 filed Sep. 30, 2003. The entirety of each of these patent applications is incorporated by reference herein, including all text and drawings.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3570673 | Dutz et al. | Mar 1971 | A |
| 4043905 | Novotny et al. | Aug 1977 | A |
| 4045352 | Rembaum et al. | Aug 1977 | A |
| 4214020 | Ward et al. | Jul 1980 | A |
| 4293413 | Schnell | Oct 1981 | A |
| 4293415 | Bente, III et al. | Oct 1981 | A |
| 4424127 | Roeraade | Jan 1984 | A |
| 4654265 | Kamei et al. | Mar 1987 | A |
| 4657742 | Beaver | Apr 1987 | A |
| 4689267 | Takamizawa et al. | Aug 1987 | A |
| 4715105 | Beaver | Dec 1987 | A |
| 4818264 | Langhorst | Apr 1989 | A |
| 4957620 | Cussler | Sep 1990 | A |
| 4999164 | Puchinger et al. | Mar 1991 | A |
| 5092155 | Rounbehler et al. | Mar 1992 | A |
| 5092219 | Rounbehler et al. | Mar 1992 | A |
| 5154822 | Simpson et al. | Oct 1992 | A |
| 5160627 | Cussler et al. | Nov 1992 | A |
| 5194333 | Ohnaka et al. | Mar 1993 | A |
| 5362859 | Zale | Nov 1994 | A |
| 5395521 | Jagadeeswaran | Mar 1995 | A |
| 5429746 | Shadie et al. | Jul 1995 | A |
| 5438127 | Woodard et al. | Aug 1995 | A |
| 5460781 | Hori et al. | Oct 1995 | A |
| 5552047 | Oshida et al. | Sep 1996 | A |
| 5578204 | Bartholmes et al. | Nov 1996 | A |
| 5610290 | Woodard et al. | Mar 1997 | A |
| 5616701 | Woodard et al. | Apr 1997 | A |
| 5683916 | Goffe et al. | Nov 1997 | A |
| 5774779 | Tuchinskiy | Jun 1998 | A |
| 5851491 | Moulton | Dec 1998 | A |
| 5876918 | Wainwright et al. | Mar 1999 | A |
| 6007609 | Semerdjian et al. | Dec 1999 | A |
| 6045757 | Moriarty et al. | Apr 2000 | A |
| 6048457 | Kopaciewicz et al. | Apr 2000 | A |
| 6117394 | Smith | Sep 2000 | A |
| 6123905 | Torti et al. | Sep 2000 | A |
| 6143252 | Haxo, Jr. et al. | Nov 2000 | A |
| 6162341 | Nordman et al. | Dec 2000 | A |
| 6168948 | Anderson et al. | Jan 2001 | B1 |
| 6174352 | Semerdjian et al. | Jan 2001 | B1 |
| 6174673 | Short et al. | Jan 2001 | B1 |
| 6207049 | Abdel-Rahman | Mar 2001 | B1 |
| 6231739 | Nordman et al. | May 2001 | B1 |
| 6270674 | Baurmeister et al. | Aug 2001 | B1 |
| 6306659 | Parce et al. | Oct 2001 | B1 |
| 6309828 | Schleifer et al. | Oct 2001 | B1 |
| 6325114 | Bevirt et al. | Dec 2001 | B1 |
| 6329209 | Wagner et al. | Dec 2001 | B1 |
| 6333088 | Le Febre et al. | Dec 2001 | B1 |
| 6338802 | Bodner et al. | Jan 2002 | B1 |
| 6357484 | Semerdjian et al. | Mar 2002 | B1 |
| 6387236 | Nordman et al. | May 2002 | B2 |
| 6387331 | Hunter | May 2002 | B1 |
| 6406921 | Wagner et al. | Jun 2002 | B1 |
| 6416716 | Shukla et al. | Jul 2002 | B1 |
| 6451260 | Dusterhoft et al. | Sep 2002 | B1 |
| 6482362 | Smith | Nov 2002 | B1 |
| 6537502 | Shukla et al. | Mar 2003 | B1 |
| 6566145 | Brewer | May 2003 | B2 |
| 6576478 | Wagner et al. | Jun 2003 | B1 |
| 6582969 | Wagner et al. | Jun 2003 | B1 |
| 6596237 | Borrelli et al. | Jul 2003 | B1 |
| 6596545 | Wagner et al. | Jul 2003 | B1 |
| 6635201 | Kopaciewicz et al. | Oct 2003 | B1 |
| 6638482 | Ackley et al. | Oct 2003 | B1 |
| 6640588 | Semerdjian | Nov 2003 | B2 |
| 6743633 | Hunter | Jun 2004 | B1 |
| 6759126 | Malik et al. | Jul 2004 | B1 |
| 6780314 | Jinno et al. | Aug 2004 | B2 |
| 6780582 | Wagner et al. | Aug 2004 | B1 |
| 6794127 | Lafferty et al. | Sep 2004 | B1 |
| 6830717 | Kopaciewicz et al. | Dec 2004 | B2 |
| 6866824 | Lafferty et al. | Mar 2005 | B2 |
| 6870165 | Amirkhanian et al. | Mar 2005 | B2 |
| 6875354 | Kopaciewicz et al. | Apr 2005 | B1 |
| 6886824 | Johdai et al. | May 2005 | B2 |
| 6972183 | Lafferty et al. | Dec 2005 | B1 |
| 6992181 | Tooke et al. | Jan 2006 | B2 |
| 7118657 | Golovchenko et al. | Oct 2006 | B2 |
| 7118671 | Kumakhov et al. | Oct 2006 | B2 |
| 7122640 | Gjerde et al. | Oct 2006 | B2 |
| 7151167 | Gjerde et al. | Dec 2006 | B2 |
| 7166212 | Belov et al. | Jan 2007 | B2 |
| 7208072 | Amirkhanian et al. | Apr 2007 | B2 |
| 7247469 | Wagner et al. | Jul 2007 | B2 |
| 7271895 | Khamizov et al. | Sep 2007 | B2 |
| 7276158 | Shukla et al. | Oct 2007 | B1 |
| 7309409 | Amirkhanian et al. | Dec 2007 | B2 |
| 7521020 | Gratzl et al. | Apr 2009 | B2 |
| 7595026 | Hudson | Sep 2009 | B2 |
| 7759112 | Belgrader | Jul 2010 | B2 |
| 7964097 | Belov et al. | Jun 2011 | B2 |
| 20020110495 | Hunt et al. | Aug 2002 | A1 |
| 20030007897 | Creasey | Jan 2003 | A1 |
| 20030068317 | Lee et al. | Apr 2003 | A1 |
| 20030173284 | Baker | Sep 2003 | A1 |
| 20040038316 | Kaiser et al. | Feb 2004 | A1 |
| 20040147042 | Gratzl et al. | Jul 2004 | A1 |
| 20040171166 | Hunter | Sep 2004 | A1 |
| 20040191537 | Lubda et al. | Sep 2004 | A1 |
| 20040224425 | Gjerde et al. | Nov 2004 | A1 |
| 20050003211 | Harada et al. | Jan 2005 | A1 |
| 20050019951 | Gjerde et al. | Jan 2005 | A1 |
| 20050139536 | Belov et al. | Jun 2005 | A1 |
| 20050178709 | Nakanishi et al. | Aug 2005 | A1 |
| 20050254995 | Sostek et al. | Nov 2005 | A1 |
| 20050281710 | Crabtree | Dec 2005 | A1 |
| 20060062701 | Nakamura et al. | Mar 2006 | A1 |
| 20060093518 | Shukla et al. | May 2006 | A1 |
| 20060118491 | Gjerde et al. | Jun 2006 | A1 |
| 20060201881 | Marcus et al. | Sep 2006 | A1 |
| 20060216206 | Hudson et al. | Sep 2006 | A1 |
| 20070017870 | Belov et al. | Jan 2007 | A1 |
| 20070071649 | Marcus | Mar 2007 | A1 |
| 20070075007 | Belov et al. | Apr 2007 | A1 |
| 20070111194 | Pellaux et al. | May 2007 | A1 |
| 20070116607 | Wang et al. | May 2007 | A1 |
| 20070215543 | Haidle | Sep 2007 | A1 |
| 20110210057 | Belov et al. | Sep 2011 | A1 |
| Number | Date | Country |
|---|---|---|
| 654666 | Feb 1986 | CH |
| 4443754 | Jun 1996 | DE |
| 0729028 | Aug 1996 | EP |
| 02926492 | Jun 1999 | EP |
| 61-265567 | Nov 1986 | JP |
| 06-315603 | Nov 1994 | JP |
| 08-027621 | Dec 1996 | JP |
| 11-230956 | Aug 1999 | JP |
| 11295282 | Oct 1999 | JP |
| 11-349692 | Dec 1999 | JP |
| 2000-515066 | Nov 2000 | JP |
| 2000-342982 | Dec 2000 | JP |
| 2001-074756 | Mar 2001 | JP |
| 2002-519643 | Jul 2002 | JP |
| 2002-544486 | Dec 2002 | JP |
| 2003-251122 | Sep 2003 | JP |
| 2004-160368 | Jun 2004 | JP |
| 2004-517310 | Jun 2004 | JP |
| 2004-237142 | Aug 2004 | JP |
| 2005-529335 | Sep 2005 | JP |
| 2006-509994 | Mar 2006 | JP |
| 3759910 | Mar 2006 | JP |
| 2007-255912 | Oct 2007 | JP |
| 2008-022735 | Feb 2008 | JP |
| 62-004440 | Jan 2010 | JP |
| 2060498 | May 1996 | RU |
| 2114427 | Jun 1998 | RU |
| 2190846 | Oct 2002 | RU |
| 2114427 | Jun 1998 | SU |
| WO 99067647 | Dec 1999 | WO |
| WO 0068689 | Nov 2000 | WO |
| WO 01007162 | Feb 2001 | WO |
| WO 0240131 | May 2002 | WO |
| WO 02053256 | Jul 2002 | WO |
| WO 02060115 | Aug 2002 | WO |
| WO 02063300 | Aug 2002 | WO |
| WO 03104814 | Dec 2003 | WO |
| WO 2005032688 | Apr 2005 | WO |
| WO 2006062235 | Jun 2006 | WO |
| WO 2006062236 | Jun 2006 | WO |
| WO 2006093865 | Sep 2006 | WO |
| WO 2007029616 | Mar 2007 | WO |
| WO 2008036091 | Mar 2008 | WO |
| WO 2009121032 | Oct 2009 | WO |
| WO 2009121034 | Oct 2009 | WO |
| Entry |
|---|
| Alltech Multi-Cap Capillary Column, Bulletin #356, Alltech Inc., 1997. |
| International Preliminary Report on Patentability mailed on: Apr. 3, 2006 in International Application No. PCT/US2004/32958 filed on Sep. 30, 2004 and published as: WO 05/032688 on: Apr. 14, 2005. |
| International Preliminary Report on Patentability mailed on: Apr. 5, 2007 in International Application No. PCT/US2006/36719 filed on Sep. 30, 2004 and published as: WO 08/036091 on: Mar. 27, 2008. |
| International Preliminary Report on Patentability mailed on: Mar. 29, 2009 in International Application No. PCT/US2006/36719 filed on Sep. 30, 2004 and published as: WO 08/036091 on: Mar. 27, 2008. |
| International Search Report and Written Opinion mailed on: Dec. 8, 2004 in International Application No. PCT/US2004/32958 filed on Sep. 30, 2004 and published as: WO 05/032688 on: Apr. 14, 2005. |
| Li et al., “Factors influencing polybutadiene deposition within porous chromatographic zirconia,” Journal of Chromatography A, 1997, pp. 45-52. |
| Lobinski et al., “Multicapilary column gas chromatography with element-selective detection”, Trac, Trends in Analytical Chemistry, vol. 18, No. 7, pp. 449-460, Jul. 1, 1999. |
| Multicapilarry columns BeeChrom, Product Catalog for GC, ChemSpace, 2002. |
| Pereiro et al., “Characterization of multicapillary gas chromatography—microwave-induced plasma atomic emission spectrometry for the expeditious analysis for organometallic compounds,” Journal of Chromatograpyy A, vol. 795, Issue 2, Feb. 6, 1998, pp. 359-370. |
| Sidelnikov et al. “Sol-gel multicapilary columns for gas-solid chromatography”, Journal of Chromatography, vol. 1101, No. 1-2, pp. 325-318, Jan. 6, 2006. |
| Sidelnikov et al., “Polycapilary Chromatography,” J. Rus. Chem. Soc., 47, 23-34, 2003. |
| Supplemental European Search Report mailed on: Mar. 23, 2001 in Application No. EP 068039412 filed Sep. 20, 2006. |
| Zhdanov, “Dependency of the efficiency of the multicapillary column on the liquid phase loading method,” J. Chromatogr A., Sept 12, 2001 928(2), pp. 201-207. |
| Belov, Yuri P., ChromBA Inc., and Ramachandran, S., “BioTip Pipette Tips for Sample Preparation,” Abstract submitted to the Eastern Analytical Symposium for publication at the Eastern Analytical Symposium, Somerset New Jersey Nov. 14, 2005-Nov. 17, 2005. As communicated by Yuri p. Belov on Jan. 30, 2011. |
| Belov, Yuri P., ChromBA Inc., and Ramachandran, S., “BioTip Pipette Tips for Sample Preparation,” Final Program and table of contents for the Eastern Analytical Symposium, Somerset New Jersey Nov. 14, 2005-Nov. 17, 2005. |
| Mayr et al., “Hydrophobic, Pellicular, Monolithic Capillary Columns Based on Cross-Linked Polynorbornene for Biopolymer Separations,” Anal Chem, 74, pp. 6080-6087, Dec. 1, 2002. |
| Gilar M. et al., “Purification of crude DNA oligonucleotides by solid-phase extraction and reversed-phase high-performance liquid chromatography,” Journal of Chromatography A, 890, pp. 167-177, Aug. 18, 2000. |
| Gilar M. et al., “Ion-pair reversed-phase high-performance liquid chromatography analysis of oligonucleotides: Retention prediction,” Journal of Chromatography A, 958, pp. 167-182, Jun. 7, 2002. |
| International reliminary Report on Patentability mailed on: Oct. 7, 2010 in International Application No. PCT/US2009/038688 filed on Mar. 27, 2009 and published as: WO on: Oct. 15, 2009. |
| International Search Report and Written Opinion mailed on: Nov. 17 2009 in International Application No. PCT/US2009/038688 filed on Mar. 27, 2009 and published as: WO on: Oct. 15, 2009. |
| International Preliminary Report on Patentability, mailed on: Sep. 28, 2010 in International Application No. PCT/US2009/038686 filed on Mar. 27, 2009 and published as: WO 09/121032 on: Oct. 1, 2009. |
| International Search Report and Written Opinion, mailed on: Feb. 3, 2010 in International Application No. PCT/US2009/038686 filed on Mar. 27, 2009 and published as: WO 09/121032 on: Oct. 1, 2009. |
| Office Action mailed May 17, 2012 in U.S. Appl. No: 13/105,833, filed May 11, 2011. |
| European Search Report dated: Apr. 20, 2012 in European Patent Application No. EP09723731 filed on Mar. 27, 2009. |
| Hallmark et al., “Hollow Microcapillary Arrays in Thin Plastic Films,” Advanced Engineering Materials, vol. 7, No. 6, Jun. 1, 2005 pp. 545-547. |
| Office Action mailed on Jul. 31, 2013 in U.S. Appl. No. 12/934,967, filed on Jan. 21, 2011 and published as US 2011-0107855 on May 12, 2011. |
| Office Action mailed on Sep. 11, 2013 in U.S. Appl. No. 12/934,974, filed on Dec. 22, 2010 and published as US 2011-0092686 on Apr. 21, 2011. |
| Office Action dated: Jan. 11, 2013 in U.S. Appl. No. 12/934,974, filed on: Dec. 22, 2010 and published as: 2011/0092686 on Apr. 21, 2011. |
| Office Action mailed Dec. 27, 2012 in U.S. Appl. No: 13/105,833, filed May 11, 2011. |
| European Search Report dated: Mar. 19, 2013 in European Patent Application No. EP 12173003 filed on Sep. 20, 2006. |
| Number | Date | Country | |
|---|---|---|---|
| 20110263838 A1 | Oct 2011 | US |
| Number | Date | Country | |
|---|---|---|---|
| 60507474 | Sep 2003 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 11524426 | Sep 2006 | US |
| Child | 13015400 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 10955377 | Sep 2004 | US |
| Child | 11524426 | US |
